LFC0 Stock Overview
Engages in the research and development of medical sensors for health monitoring in Norway.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
Lifecare AS Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NOK 1.51 |
52 Week High | NOK 5.92 |
52 Week Low | NOK 1.18 |
Beta | -0.22 |
11 Month Change | 18.13% |
3 Month Change | 1.55% |
1 Year Change | -34.96% |
33 Year Change | -41.11% |
5 Year Change | n/a |
Change since IPO | -61.28% |
Recent News & Updates
Recent updates
Shareholder Returns
LFC0 | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | -7.4% | -1.3% | 0.02% |
1Y | -35.0% | 8.2% | 19.6% |
Return vs Industry: LFC0 underperformed the German Medical Equipment industry which returned 8.2% over the past year.
Return vs Market: LFC0 underperformed the German Market which returned 19.6% over the past year.
Price Volatility
LFC0 volatility | |
---|---|
LFC0 Average Weekly Movement | 23.2% |
Medical Equipment Industry Average Movement | 5.3% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 11.4% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: LFC0's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: LFC0's weekly volatility (23%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | 32 | Joacim Holter | www.lifecare.no |
Lifecare AS engages in the research and development of medical sensors for health monitoring in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes. It manufactures and develops nanostrain biosensors for measuring pressure and temperature in live tissue.
Lifecare AS Fundamentals Summary
LFC0 fundamental statistics | |
---|---|
Market cap | €24.09m |
Earnings (TTM) | -€4.21m |
Revenue (TTM) | €1.36m |
17.7x
P/S Ratio-5.7x
P/E RatioIs LFC0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
LFC0 income statement (TTM) | |
---|---|
Revenue | NOK 16.10m |
Cost of Revenue | NOK 0 |
Gross Profit | NOK 16.10m |
Other Expenses | NOK 65.93m |
Earnings | -NOK 49.84m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 13, 2024
Earnings per share (EPS) | -3.14 |
Gross Margin | 100.00% |
Net Profit Margin | -309.61% |
Debt/Equity Ratio | 0% |
How did LFC0 perform over the long term?
See historical performance and comparison